DeutschNewstral
Article
Financial Times on 2023-01-10 02:47
Pfizer Inc: Pfizer says it could start making Paxlovid in China in 3-4 months
Related news
China and Pfizer fail to reach Paxlovid public insurance dealSouth China Morning Post
Pfizer to sell Paxlovid in China as COVID cases surgeseattletimes.com
China gives conditional approval for Pfizer COVID pill PaxlovidAl Jazeera
Pfizer pill ‘Paxlovid’ becomes first US-authorized home COVID treatmentThe Hindu
Enanta Pharmaceuticals sues Pfizer for patent infringement involving Paxlovidbizjournals.com
Pfizer sued for patent infringement in Paxlovid developmentisraelnationalnews.com
Pfizer and Moderna start trials on kids as young as 6 monthsCNN
Pfizer-BioNTech start trials of new Omicron jabBBC- Pfizer Inc: Pfizer forecasts weak sales as demand for Covid products slowsFinancial Times
- LVEGF Inhibitor Drugs Market 2021 High Growth Forecast due to Rising Demand and Future Trends | Key Companies: Pfizer, Merck & Co., Inc., Sanofi, Novartis AG, Genentech, Inc. (Roche), GlaxoSmithKlin…liverpoolstudentmedia.com
- Pfizer says locally produced Covid pills may be available in China within the next few monthsSouth China Morning Post
- Pfizer says Covid-19 pill Paxlovid cuts hospitalisation and deaths by 89 per centSouth China Morning Post
- MPfizer says Paxlovid doesn't help COVID-19 patients unless they are high risk3 min readmarketwatch.com
- BPfizer Brought Us a Covid Vaccine and Paxlovid. Here’s What’s Next.1 min readbarrons.com
Pfizer more than doubles price of life-saving COVID antiviral, PaxlovidArs Technica- BPfizer CEO: Covid Infections Will Rise. So Will Paxlovid and Vaccine Sales.3 min readbarrons.com
- Pfizer Inc: Pfizer pins hopes on record pipeline to recover from post-Covid hangoverFinancial Times
- Pfizer Inc: Pfizer shifts focus to shareholder returns after sharp revenue dropFinancial Times